Display of quintuple glucagon-like peptide 1 (28-36) nonapeptide on Bacillus subtilis spore for oral administration in the treatment of type 2 diabetes.

M KangF FengQ GeF ZhuL ChenPeng LüS MaQ YaoKe-Ping Chen

Published in: Journal of applied microbiology (2020)

The results of this study revealed that GLP-1(28-36) nonapeptides can reduce blood glucose and play an important role in the treatment of type 2 diabetes.

Keyphrases

blood glucose
bacillus subtilis
type diabetes
metabolic syndrome
combination therapy
glycemic control
weight loss
smoking cessation